Methamnetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 18:51, 17 April 2020 (Added FDA UNII (not yet published)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Methamnetamine
Legal status
Legal status
Identifiers
  • N-Methyl-1-(naphthalen-2-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H17N
Molar mass199.297 g·mol−1
3D model (JSmol)
  • CNC(C)Cc1ccc2ccccc2c1
  • InChI=1S/C14H17N/c1-11(15-2)9-12-7-8-13-5-3-4-6-14(13)10-12/h3-8,10-11,15H,9H2,1-2H3
  • Key:BWWWOLYZMKACSB-UHFFFAOYSA-N

Methamnetamine (also known as methylnaphetamine, MNA, MNT and PAL-1046) is a triple monoamine releasing agent and N-methyl analog of the non-neurotoxic experimental drug naphthylaminopropane and the naphthalene analog of methamphetamine.[1] It has been sold online as a designer drug.[2][3]

It acts as a releasing agent of serotonin, norepinephrine, and dopamine, with EC50 values of 13 nM, 34 nM, and 10 nM, respectively.[1]

Legal status

Methamnetamine is illegal in Japan.[4]

See also

References

  1. ^ a b Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE (April 2012). "Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters". The Journal of Pharmacology and Experimental Therapeutics. 341 (1): 251–62. doi:10.1124/jpet.111.188946. PMC 3364510. PMID 22271821.
  2. ^ "Methamnetamine". WEDINOS.
  3. ^ "Methamnetamine". New Synthetic Drugs Database.
  4. ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" (PDF) (in Japanese). 厚生労働省. 16 September 2015. Retrieved 8 October 2015.